批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/09/28 |
SUPPL-57(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/07/14 |
SUPPL-52(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2015/03/31 |
SUPPL-51(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/01/22 |
SUPPL-49(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/05/03 |
SUPPL-47(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/08/30 |
SUPPL-43(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/04/30 |
SUPPL-42(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/10/08 |
SUPPL-41(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2006/03/06 |
SUPPL-40(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/07/19 |
SUPPL-39(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/02/06 |
SUPPL-37(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/02/06 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/02/14 |
SUPPL-29(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/02/14 |
SUPPL-27(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2002/06/14 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/04/12 |
SUPPL-33(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/02/22 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/01/16 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/11/16 |
SUPPL-28(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/10/04 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/12/21 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/05/13 |
SUPPL-24(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/10/20 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/07/27 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/03/30 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1998/01/30 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1996/08/09 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1996/03/22 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/11/21 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1995/04/28 |
SUPPL-16(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1995/03/07 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/11/10 |
SUPPL-15(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1994/05/19 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/05/09 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1994/05/09 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/03/19 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/02/24 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/02/16 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1993/02/11 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1992/02/21 |
SUPPL-8(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1991/06/10 |
SUPPL-6(补充) |
Approval |
Labeling |
|
|
|
1991/03/14 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
1983/11/14 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:CYCLOSPORINE 剂型/给药途径:SOLUTION;ORAL 规格:100MG/ML 治疗等效代码:AB2
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
050574 |
001 |
NDA |
SANDIMMUNE |
CYCLOSPORINE |
SOLUTION;ORAL |
100MG/ML |
Prescription |
Yes |
Yes |
AB2 |
1983/11/14
|
NOVARTIS |
065133 |
001 |
ANDA |
CYCLOSPORINE |
CYCLOSPORINE |
SOLUTION;ORAL |
100MG/ML |
Discontinued |
No |
No |
AB2 |
2004/09/17
|
PHARMOBEDIENT CNSLTG |